- Home
- CAPR vs GF Comparison
CAPR vs GF Comparison
Compare CAPR & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- GF
- Stock Information
- Founded
- CAPR 2005
- GF 1990
- Country
- CAPR United States
- GF Germany
- Employees
- CAPR N/A
- GF N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- GF Investment Managers
- Sector
- CAPR Health Care
- GF Finance
- Exchange
- CAPR Nasdaq
- GF Nasdaq
- Market Cap
- CAPR 332.5M
- GF 141.7M
- IPO Year
- CAPR N/A
- GF N/A
- Fundamental
- Price
- CAPR $18.49
- GF $8.71
- Analyst Decision
- CAPR Strong Buy
- GF
- Analyst Count
- CAPR 5
- GF 0
- Target Price
- CAPR $35.60
- GF N/A
- AVG Volume (30 Days)
- CAPR 8.2M
- GF 28.1K
- Earning Date
- CAPR 11-12-2024
- GF 01-01-0001
- Dividend Yield
- CAPR N/A
- GF 0.82%
- EPS Growth
- CAPR N/A
- GF N/A
- EPS
- CAPR N/A
- GF N/A
- Revenue
- CAPR $27,152,218.00
- GF N/A
- Revenue This Year
- CAPR N/A
- GF N/A
- Revenue Next Year
- CAPR $209.81
- GF N/A
- P/E Ratio
- CAPR N/A
- GF N/A
- Revenue Growth
- CAPR 187.15
- GF N/A
- 52 Week Low
- CAPR $2.68
- GF $7.38
- 52 Week High
- CAPR $23.40
- GF $9.41
- Technical
- Relative Strength Index (RSI)
- CAPR 62.83
- GF 54.54
- Support Level
- CAPR $15.34
- GF $8.66
- Resistance Level
- CAPR $23.40
- GF $8.76
- Average True Range (ATR)
- CAPR 3.44
- GF 0.06
- MACD
- CAPR 0.08
- GF -0.02
- Stochastic Oscillator
- CAPR 63.71
- GF 27.78
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a United States-based non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.